Insilicos Nabs $900K Grant From NIH

Luke Timmerman12/18/08

Insilicos, a Seattle-based company that makes software for drug researchers, said today it has won a $900,000 grant from the National Institutes of Health. The money will be used to study “ensemble learning,” which uses a blend of statistical models to make a more accurate prediction about a biological experiment than a single model. Insilicos is also working on improving diagnostic tests for cardiovascular disease.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.